Gene Therapy Market Worldwide Growth, Industry Analysis, Regional Overview, Size and Share Forecast to 2028

 The global gene therapy market is likely to grow at an impressive CAGR over the forecast period, owing to recent technological advancements in gene replacement procedures. According to a report by Fortune Business Insights, titled ‘Gene Therapy: Global Market Analysis, Insights and Forecast, 2018 - 2025’ the market is likely to expand at a high rate due to increasing adoption of gene therapy in several countries across the world.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/gene-therapy-market-100243

Recently, there has been a growing emphasis on development of new gene replacement therapies. Encouraged by advancements in gene therapy and a high demand from end users, many companies are investing more in the research and development (R&D) of these products. According to Fortune Business Insights, in the coming years the market is likely to gain from the rising demand for gene therapy for haemophilia and other diseases.

some of the key players in the global Gene Therapy Market:

  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Sanofi
  • GlaxoSmithKline plc.
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH
  • uniQure N.V.
  • bluebird bio, Inc.
  • Celgene Corporation

The exceptional benefits of gene therapy include replacement of a defective gene altogether. In initial years, research analysts were more focused on repairing the defective genes, but with the option of replacing the gene altogether, more end users are opting for gene therapy process. This factor has had a positive impact on the global gene therapy market and the increasing adoption is likely to drive the market in the forecast period.

Introduction of New Tools in Gene Therapy to Drive the Market

Regenerative medicine is an emerging area of research and development, with research analysts expressing their intent of emphasizing on developments in gene therapy. As gene therapies involve infusion of new genes into cells for regeneration of tissues, tools used for these therapies need to be precise and of high calibre. Thus, the focus of existing companies is gradually shifting towards the development of novel and more advanced tools. This offers growth opportunities for existing as well as new players in the market.

Comments

Post a Comment

Popular posts from this blog

Contraceptive Pills Market Size, Revenue, Growth Development, Opportunities, Trends by 2026

  The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs. For more information in the analysis of this report, visit:  https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802 The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace.
Read more

MicroRNA Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2025

  The global microRNA market size is expected to showcase exponential growth by reaching USD 613.2 million by 2027 while exhibiting a CAGR of 13.4% between 2020 and 2027. This growth is attributable to the increasing prevalence of chronic diseases such as Cancer and the growing focus on adoption of advanced technology in microRNA research across the globe. This information is published by Fortune Business Insights in its latest report, titled,   “MicroRNA Market Size, Share & Covid-19 Impact Analysis, By Product (Instruments and Kits & Reagents) By Application (Isolation & Purification, Detection & Quantification, Disease Diagnostics, and Others) and By End User (Pharma & Biotech Companies, Academic & Research Institutes, Healthcare Facilities, and Others), 2020-2027.”  The report further mentions that the market stood at USD 215.4 million in 2019. For more information in the analysis of this report, visit:  https://www.fortunebusinessinsights.com/industry-repor
Read more